![BIOS: Clinical Trials Coordinating Center](/img/default-banner.jpg)
- 12
- 320
BIOS: Clinical Trials Coordinating Center
Приєднався 12 вер 2017
BIOS Clinical Trials Coordinating Center is an academic research organization within the Johns Hopkins School of Medicine. Its focus is to provide multicenter coordinating infrastructure to a variety of clinical trials evaluating therapeutic, preventive, and diagnostic interventions. Home to the NCATS-sponsored Johns Hopkins University Trial Innovation Center (JHU TIC), BIOS CTCC is disease-agnostic with unique expertise in the coordination and management of trials investigating rare diseases and disorders, acute neurologic ICU conditions, rehabilitation, pain management, and functional outcomes.
Winter 2025 DIDACT Symposium Q&A
Panelists respond to further questions at the winter 2025 DIDACT Symposium on January 16, 2025.
The DIDACT Symposium series is a project of the Trial Innovation Network.
The DIDACT Symposium series is a project of the Trial Innovation Network.
Переглядів: 13
Відео
How to Characterize Groups of Individuals with Large Effects
Переглядів 1214 днів тому
Constantine Frangakis, PhD, presents "How to Characterize Groups of Individuals with Large Effects" at the winter 2025 DIDACT Symposium on January 16, 2025. The DIDACT Symposium series is a project of the Trial Innovation Network.
Design for Diversity: Designing Studies for Representativeness and Generalizability
Переглядів 2114 днів тому
Chris Lindsell, PhD, presents "Design for Diversity: Designing Studies for Representativeness and Generalizability" at the winter 2025 DIDACT Symposium on January 16, 2025. The DIDACT Symposium series is a project of the Trial Innovation Network.
Augmenting Clinical Trials With External Data
Переглядів 1214 днів тому
Issa Dahabreh, PhD, ScD, presents "Augmenting Clinical Trials With External Data" at the winter 2025 DIDACT Symposium on January 16, 2025. The DIDACT Symposium series is a project of the Trial Innovation Network.
Individualized Treatment Effects for Using a Flexible Bayesian Approach
Переглядів 2114 днів тому
Ravi Varadhan, PhD, presents "Individualized Treatment Effects for Using a Flexible Bayesian Approach" at the winter 2025 DIDACT Symposium on January 16, 2025. The DIDACT Symposium series is a project of the Trial Innovation Network.
Fall 2024 DIDACT Symposium Q&A
Переглядів 203 місяці тому
Panelists respond to further questions at the fall 2024 DIDACT Symposium on October 18, 2024. The DIDACT Symposium series is a project of the Trial Innovation Network.
Sequential, Multiple Assignment, Randomized Trial (SMART) Design Approaches in Clinical Trials
Переглядів 333 місяці тому
Kelley Kidwell, PhD, presents "Sequential, Multiple Assignment, Randomized Trial (SMART) Design Approaches in Clinical Trials" at the fall 2024 DIDACT Symposium on October 18, 2024. The DIDACT Symposium series is a project of the Trial Innovation Network.
Platform, Adaptive, and Decentralized Trials: New REDCap Randomization Capabilities
Переглядів 353 місяці тому
Jonathan Casey, MD, presents "Platform, Adaptive, and Decentralized Trials: New REDCap Randomization Capabilities" at the fall 2024 DIDACT Symposium on October 18, 2024. The DIDACT Symposium series is a project of the Trial Innovation Network.
An Example of Bayesian Fully Sequential Clinical Trial Design and its Performance
Переглядів 293 місяці тому
Frank Harrell, PhD, presents "An Example of Bayesian Fully Sequential Clinical Trial Design and its Performance" at the fall 2024 DIDACT Symposium on October 18, 2024. The DIDACT Symposium series is a project of the Trial Innovation Network.
Improving Precision in Estimating Marginal Treatment Effects in Randomized Trials
Переглядів 263 місяці тому
Michael Rosenblum, PhD, and Joshua Betz, MS, present "Improving Precision in Estimating Marginal Treatment Effects in Randomized Trials" at the fall 2024 DIDACT Symposium on October 18, 2024. The DIDACT Symposium series is a project of the Trial Innovation Network.
COVID-19 Convalescent Plasma Trial: Overview & Results (CSSC-004 Participant Webinar 6/20/22)
Переглядів 492 роки тому
A month after a person has recovered from COVID-19, a high level of viral killing, neutralizing antibodies exist in the plasma. Taking a cup of plasma with these antibodies and giving them to a person with a new COVID-19 infection has the potential to prevent hospitalization or deaths. The efficacy for most viral diseases is greater the earlier these antibodies are given. Waiting until people r...
2017 09 05 14 02 MISTIE III Monthly Webinar 2pm
Переглядів 557 років тому
2017 09 05 14 02 MISTIE III Monthly Webinar 2pm